Skip to content
Screener

Total Revenue at other companies

GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$5.3B+5.8%
Immunome logo
ImmunomeIMNM
$0-100%
RadNet logo
RadNetRDNT
$575.63M+22.1%
BillionToOne, Inc. logo
BillionToOne, Inc.BLLN
$109.45M+64.4%
CTO
Citius Oncology, Inc.CTOR
$1.67M
Revvity logo
RevvityRVTY
$711.12M+7.0%

Segments

By product

See full
Oncology$240.37M
PYLARIFY$240.37M-4.1%
Cardiology$88.28M
Definity$88.28M+5.2%
Neuraceq$39.62M
Neurology$39.62M

By geography

See full
US$356.3M-4.0%

Other financials

Income statement

See full
Gross profit$241.9M+0.4%
Operating income$100.2M+13.9%
Net income$75.0M-4.7%
EPS (diluted)$1.11-0.9%

Balance sheet

See full
Cash & equivalents$595.0M-14.7%
Total debt$626.8M+1.5%
Total equity$1.3B+12.4%
Total assets$2.4B+14.1%

Cash flow

See full
Operating cash flow$92.2M+5.9%
CapEx$2.3M-70.7%
Free cash flow$89.9M+13.5%

Valuation

See full
Market cap$6.63B+84.6%
Enterprise value$6.66B+89.7%
P/E24.1×+11.4×
P/S4.3×+1.9×

Profitability

See full
Gross margin60.1%-3.6pp
Operating margin19.4%-9.4pp
Net margin17.7%-0.9pp
FCF margin24.9%-6.6pp

Returns & leverage

See full
Return on equity22.2%-3.6pp
Debt / equity0.5×-0.1×
Current ratio3.1×-1.2×

Where this comes from

Reported directly by Lantheus Holdings in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Lantheus Holdings’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 8:01 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336795
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Revenues$388,180$378,045$765,513$750,809
Cost of goods sold146,325137,034292,736272,098
Gross profit241,855241,011472,777478,711
Operating expenses
Sales and marketing82,80541,041135,48983,544
General and administrative20,63366,51578,166123,331
Research and development38,20245,48977,58181,803
Total operating expenses141,640153,045291,236288,678

Item 1. Financial Statements

FAQ

What is Lantheus Holdings's total revenue?
Lantheus Holdings (LNTH) reported total revenue of $388.18M in Q2 2026.
How has Lantheus Holdings's total revenue changed year-over-year?
Lantheus Holdings's total revenue increased by 2.7% year-over-year, from $378.05M to $388.18M.
What is the long-term trend for Lantheus Holdings's total revenue?
Over 4 years (2021 to 2025), Lantheus Holdings's total revenue has grown at a 38.0% compound annual growth rate (CAGR), from $425.21M to $1.54B.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Lantheus Holdings's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude